HIV-1 acute infection: evidence for selection?

Size: px
Start display at page:

Download "HIV-1 acute infection: evidence for selection?"

Transcription

1 HIV-1 acute infection: evidence for selection? ROLLAND Morgane University of Washington

2 Cohort & data S6 S5 T4 S4 T2 S2 T1 S1 S7 T3 DPS (days post symptoms) 3 (Fiebig I) 7 (Fiebig I) 13 (Fiebig V) 14 (Fiebig I) 3 (Fiebig I) 8 (Fiebig I) 3 (Fiebig I) Eleven HIV-1 subtype B infected individuals from the Seattle Primary Infection Cohort (SeaPIC) Near full length genomes (~9,1 Kb) were amplified from plasma by singletemplate PCR, cloned and sequenced 495 HIV-1 subtype B genomes Eight individuals were enrolled during acute HIV-1 infection Four transmission pairs 25 (Fiebig V) HXB2 acute infection

3 A single founder variant typically establishes HIV-1 infection S5 T2 S2 Phylogenetic tree with sequences from the first time point after infection in recipients: A single HIV-1 variant established infection in 8 of the 9 MSM HXB2 S6 T1 Li et al. PLoS Pathogens S1 S7 S4 T4 T3 MSM: 31/50 = 62% HSX: 141/175 subjects = 81% (p = 0.008) Other MSM cohorts: 77% of 64 Step vaccine trial volunteers infected with subtype B (Rolland, Stovanabutra, decamp et al., submitted) 86% of 37 MSM evaluated preseroconversion in the MACS cohort (Gottlieb et al., 2008)

4 Comparison of sequences from transmission pairs HXB2 S2, sampled at 3 dps Sample from T2 on same day, sampled at 25 dps Sample from T3 8 days later S4, sampled at 13 dps Sample from T4 10 days later S1, sampled at 8 dps Sample from T1 17 days later S1 S2 T2, 14 dps S4 T3, 9 yrs T4, 9 yrs T1, 10 yrs Restriction to a single founder not due to lack of variation in transmitter Comparison between the genome sequences from the transmitter and genomes from visit 1 in the recipient No exact match at the genome level; exact match in gag or pol Closest match: : 98.31% identity to a genome from T3 S4: 98.89% identity to a genome from T4 S1: 99.28% identity to a genome from T1 S2: 99.82% identity to a genome from T2

5 Comparison to the consensus from the transmitter S2, sampled at 3 dps Sample from T2 on same day S2 T2, 14 dps T3, 9 yrs Divergence from transmitter consensus p = 0.84, sampled at 25 dps Sample from T3 8 days later T2 S2 S4, sampled at 13 dps Sample from T4 10 days later S T3 p = T4, 9 yrs S1, sampled at 8 dps Sample from T1 17 days later S T S4 p = 0.68 T1, 10 yrs HXB2 Consensus from transmitter sequences T S1 p = 0.58

6 Comparison to the consensus from the transmitter Divergence from transmitter consensus T T3 p = T T1 p = S2 p = S4 p = S1 The founder variant: did not correspond to the consensus from the transmitter seemed to be a rare variant in the transmitter, that nonetheless was within the distribution of variants found in the transmitter, except in the case of. The genomes from were significantly more divergent than any genome in the transmitter. Lack of exact match can be due to: Insufficient or non-simultaneous sampling Compartmentalization: plasma vs semen Selection for viruses better adapted to the new host

7 ELISpot assays with transmitter- and recipient-specific peptides Predicted epitopes Forward mutation Decrease in database frequency by >50% between: 1) the AA in the transmitter and the AA in the recipient 2) the consensus AA in the recipient and the mutated AA Reverse mutation Increase in database frequency by >50% ELISpot responses assays Hypothesis: Sites that differ between transmitter and recipient may correspond to sites under CTL pressure in the transmitter, that reverted back to a consensus-like form upon transmission to a new host One example of a CTL response directed against a Nef region in the transmitter

8 Longitudinal follow-up Follow-up between: S6 3 and 350 dps, 12 visits 123 genomes S5 7 and 181 dps, 8 visits 85 genomes T4, S4 HXB2 T2, S2 T1, S1 S7 T3 3 and 196 dps, 7 visits, 68 genomes 25 and 247 dps, 9 visits, 93 genomes

9 Diversification over time Pairwise diversity, genomes dps Rate of diversification, % per year genome S5 S6 S7 gag pol env, C2V5 nef The rate of evolution varied across the genome; it was higher in env and nef. The rates seen in C2V5 are comparable to the rates reported in chronic infection (0.92%+/-0.29, Shankarappa et al., 1999)

10 A dip in nucleotide diversity in acute infection Pairwise diversity, based on genomes, normalized to zero at visit 1 S6 S7 S dps The pairwise nucleotide diversity decreased in the earliest time points of infection.

11 A dip in APOBEC3G-mediated mutations APOBEC3G S6 APOBEC3G diversity S7 Pairwise diversity, genomes Control G>A mutations S5 Diversity in S6 Diversity in S5 Diversity in S7 Diversity in APOBEC3G dps Control G>A mutations The dip in APOBEC3G-mediated mutations was parallel to the dip in nucleotide diversity Yet, the dip in APOBEC3G-induced mutations was not the cause of the dip in nucleotide diversity.

12 Demographic processes dominate in acute infection Viral loads (x100,000) Viral loads S6 S7 Pairwise diversity, genomes Diversity Significant deviations in neutrality tests S5 Diversity in S6 Diversity in S5 Diversity in S7 Diversity in At the genome level, neutrality tests (Tajima s D and Fu and Li s D*) showed negative deviations from the neutral model, suggesting alternative hypotheses, such as selection or demographic history: founder effects, changes in population size or purifying selection can lead to strong negative deviations. Genome-wide and gene-specific tests were congruent, thus showing the predominance of demographic processes in acute infection. The dip in diversity is likely due to the single variant-founder effect and the subsequent delay before the viral population reaches equilibrium dps

13 Signs of selection appear at 1-2 weeks post symptoms The earliest fixation of an AA substitution occurred at day 21 in Tat (S5) By 6 months post-infection, there were between 9 (in S6) and 18 (in S7) positively selected sites across the genome. Mutually-exclusive substitution patterns in predicted CTL epitopes More evidence of forward ( escape ) than reverse mutations: S7: 37 forward vs. 2 reverse mutations S5: 53 forward vs. 7 reverse mutations S6: 91 forward vs. 7 reverse mutations : 55 forward vs. 10 reverse mutations X X Forward mutation Reverse mutation

14 Conclusion HIV-1 acute infection is characterized by a founder effect with single variants establishing infection in 81 % of individuals (based on 110 MSM) The variants establishing infection in the recipient did not correspond to the consensus variant in the transmitter. Demographic processes dominated in the earliest weeks of infection Founder effect (short branch lengths to the MRCA) and multiplicity of variable sites (star-like phylogeny) led to significant negative deviations from the neutral model. Across transmission pairs and over time in the recipients, we found more evidence of forward ( escape ) than reverse mutations Mutually-exclusive substitution patterns in predicted CTL epitopes

15 Acknowledgments James I. Mullins Joshua T. Herbeck Seattle Primary Infection Cohort Yi Liu Sherry McLaughlin Hong Zhao Kim Wong Julia N. Stoddard Dana Raugi Stephanie Sorensen Indira Genowati Brian Birditt Angela McKay Brandon S. Maust Wenjie Deng M. Juliana McElrath John McNevin Nicole Frahm Justine E. Brown Kurt Diem Joanne D. Stekler Ann C. Collier

Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes

Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes JOURNAL OF VIROLOGY, Aug. 2011, p. 7523 7534 Vol. 85, No. 15 0022-538X/11/$12.00 doi:10.1128/jvi.02697-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Demographic Processes Affect

More information

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial CORRECTION NOTICE Nat. Med. 17, 366 371 (2011) Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial Morgane Rolland, Sodsai Tovanabutra, Allan C decamp, Nicole Frahm, Peter

More information

Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection

Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection Anne Piantadosi 1,2[, Bhavna Chohan 1,2[, Vrasha Chohan 3, R. Scott McClelland 3,4,5, Julie Overbaugh 1,2* 1 Division of Human

More information

Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection

Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection JOURNAL OF VIROLOGY, Oct. 2006, p. 9519 9529 Vol. 80, No. 19 0022-538X/06/$08.00 0 doi:10.1128/jvi.00575-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Selection on the Human

More information

On an individual level. Time since infection. NEJM, April HIV-1 evolution in response to immune selection pressures

On an individual level. Time since infection. NEJM, April HIV-1 evolution in response to immune selection pressures HIV-1 evolution in response to immune selection pressures BISC 441 guest lecture Zabrina Brumme, Ph.D. Assistant Professor, Faculty of Health Sciences Simon Fraser University http://www3.niaid.nih.gov/topics/hivaids/understanding/biology/structure.htm

More information

Understanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute

Understanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute Understanding HIV Transmission Utilizing Transmitted/Founder Viruses Brandon Keele SAIC-Frederick National Cancer Institute AIDS Vaccine 2011 15 September 2011 Overview Several years ago, the CHAVI sought

More information

HIV-1 Dual Infection and Neurocognitive Impairment

HIV-1 Dual Infection and Neurocognitive Impairment HIV-1 Dual Infection and Neurocognitive Impairment Gabriel Wagner, MD Assistant Professor of Medicine Infectious Diseases & Global Public Health UC San Diego HIV-Associated End Organ Damage Antiretroviral

More information

How HIV Causes Disease Prof. Bruce D. Walker

How HIV Causes Disease Prof. Bruce D. Walker How HIV Causes Disease Howard Hughes Medical Institute Massachusetts General Hospital Harvard Medical School 1 The global AIDS crisis 60 million infections 20 million deaths 2 3 The screen versions of

More information

Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients

Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients Ling Yue, Emory University Katja J. Pfafferott, University of Oxford Joshua

More information

Evolution of influenza

Evolution of influenza Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal

More information

Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants

Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants Pandit and de Boer Retrovirology 2014, 11:56 RESEARCH Open Access Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants

More information

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside UvA-DARE (Digital Academic Repository) RNAi based gene therapy for HIV-1, from bench to bedside Von Eije, K.J. Link to publication Citation for published version (APA): Von Eije, K. J. (2009). RNAi based

More information

Higher priming doses enhance HIV-specific humoral but not cellular. responses in a randomized, double-blind phase Ib clinical trial of

Higher priming doses enhance HIV-specific humoral but not cellular. responses in a randomized, double-blind phase Ib clinical trial of Higher priming doses enhance HIV-specific humoral but not cellular responses in a randomized, double-blind phase Ib clinical trial of preventive HIV-1 vaccines Pierre-Alexandre Bart a,b, Yunda Huang c,

More information

HIV Diversity in East Africa

HIV Diversity in East Africa HIV Diversity in East Africa Kayvon Modjarrad, M.D., Ph.D. 16 March 2015 The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department

More information

Frequency and Dynamics of Transmitted Polymorphisms and their Impact on Early Pathogenesis in Heterosexual Couples in Zambia

Frequency and Dynamics of Transmitted Polymorphisms and their Impact on Early Pathogenesis in Heterosexual Couples in Zambia Frequency and Dynamics of Transmitted Polymorphisms and their Impact on Early Pathogenesis in Heterosexual Couples in Zambia 8 th International Workshop on HIV Transmission Principles of Intervention Barcelona,

More information

Within-host and between-host evolutionary rates across the HIV-1 genome

Within-host and between-host evolutionary rates across the HIV-1 genome Alizon and Fraser Retrovirology 2013, 10:49 RESEARCH Open Access Within-host and between-host evolutionary rates across the HIV-1 genome Samuel Alizon 1* and Christophe Fraser 2 Abstract Background: HIV

More information

HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS

HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS Somda&a Sinha Indian Institute of Science, Education & Research Mohali, INDIA International Visiting Research Fellow, Peter Wall Institute

More information

A new wild-type in the era of transmitted drug resistance

A new wild-type in the era of transmitted drug resistance A new wild-type in the era of transmitted drug resistance EHR 2018 Rome KU Leuven 1 A new wild-type in the era of transmitted drug resistance? KU Leuven 2 Measurably evolving viruses Evolutionary rate

More information

An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs. Debrah Boeras Emory University October 14, 2008

An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs. Debrah Boeras Emory University October 14, 2008 An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs Debrah Boeras Emory University October 14, 2008 Background A majority of HIV-1 infections occur through heterosexual exposure

More information

Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution.

Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution. Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution. Brian T. Foley, PhD btf@lanl.gov HIV Genetic Sequences, Immunology, Drug Resistance and Vaccine Trials

More information

NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections

NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections Amy Chung Dr. Ivan Stratov Prof. Stephen Kent ADCC process consists of Target cell QuickTime and a TIFF (Uncompressed) FcγR decompressor

More information

HIV acute infections and elite controllers- what can we learn?

HIV acute infections and elite controllers- what can we learn? HIV acute infections and elite controllers- what can we learn? Thumbi Ndung u, BVM, PhD KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) and HIV Pathogenesis Programme (HPP), Doris Duke

More information

Innate and Cellular Immunology Control of Infection by Cell-mediated Immunity

Innate and Cellular Immunology Control of Infection by Cell-mediated Immunity Innate & adaptive Immunity Innate and Cellular Immunology Control of Infection by Cell-mediated Immunity Helen Horton PhD Seattle Biomedical Research Institute Depts of Global Health & Medicine, UW Cellular

More information

Characterizing intra-host influenza virus populations to predict emergence

Characterizing intra-host influenza virus populations to predict emergence Characterizing intra-host influenza virus populations to predict emergence June 12, 2012 Forum on Microbial Threats Washington, DC Elodie Ghedin Center for Vaccine Research Dept. Computational & Systems

More information

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4

More information

Mina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia

Mina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia Mina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia AIDSvaccine conference, 14 th September 2011 IMGT HLA database July 2011 >5000 class

More information

T cell Vaccine Strategies for HIV, the Virus. With a Thousand Faces

T cell Vaccine Strategies for HIV, the Virus. With a Thousand Faces JVI Accepts, published online ahead of print on 13 May 2009 J. Virol. doi:10.1128/jvi.00114-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

HIV Life Cycle & Genetics

HIV Life Cycle & Genetics HIV Life Cycle & enetics! etroviruses (and transposable elements) appear to be part of every cell's genome! From bacteria to yeast, flies, fish, and humans! ome endogenous retroviruses (most notably in

More information

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter Prevention of infection 2 : immunisation How infection influences the host : viruses Peter Balfe, p.balfe@bham.ac.uk @pbalfeuk Let s have some LO s just for fun 1. Define the Immune response to viruses,

More information

Search for the Mechanism of Genetic Variation in the pro Gene of Human Immunodeficiency Virus

Search for the Mechanism of Genetic Variation in the pro Gene of Human Immunodeficiency Virus JOURNAL OF VIROLOGY, Oct. 1999, p. 8167 8178 Vol. 73, No. 10 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Search for the Mechanism of Genetic Variation

More information

Multiple sequence alignment

Multiple sequence alignment Multiple sequence alignment Bas. Dutilh Systems Biology: Bioinformatic Data Analysis Utrecht University, February 18 th 2016 Protein alignments We have seen how to create a pairwise alignment of two sequences

More information

Population-level Immune-mediated Adaptation in HIV-1 Polymerase during the North American Epidemic

Population-level Immune-mediated Adaptation in HIV-1 Polymerase during the North American Epidemic JVI Accepted Manuscript Posted Online 11 November 2015 J. Virol. doi:10.1128/jvi.02353-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

More information

Rajesh Kannangai Phone: ; Fax: ; *Corresponding author

Rajesh Kannangai   Phone: ; Fax: ; *Corresponding author Amino acid sequence divergence of Tat protein (exon1) of subtype B and C HIV-1 strains: Does it have implications for vaccine development? Abraham Joseph Kandathil 1, Rajesh Kannangai 1, *, Oriapadickal

More information

Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice October 26, 2012

Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice October 26, 2012 Emerging Diseases Biosciences in the 21 st Century Dr. Amber Rice October 26, 2012 Outline Disease emergence: a case study Introduction to phylogenetic trees Introduction to natural selection How do pathogens

More information

Impact of Mutations in Highly Conserved Amino Acids of the HIV-1 Gag-p24 and Env-gp120 Proteins on Viral Replication in Different Genetic Backgrounds

Impact of Mutations in Highly Conserved Amino Acids of the HIV-1 Gag-p24 and Env-gp120 Proteins on Viral Replication in Different Genetic Backgrounds Impact of Mutations in Highly Conserved Amino Acids of the HIV-1 Gag-p24 and Env-gp120 Proteins on Viral Replication in Different Genetic Backgrounds Yi Liu 1 *, Ushnal Rao 1, Jan McClure 1, Philip Konopa

More information

RAISON D ETRE OF THE IMMUNE SYSTEM:

RAISON D ETRE OF THE IMMUNE SYSTEM: RAISON D ETRE OF THE IMMUNE SYSTEM: To Distinguish Self from Non-Self Thereby Protecting Us From Our Hostile Environment. Innate Immunity Adaptive Immunity Innate immunity: (Antigen - nonspecific) defense

More information

Lecture 11. Immunology and disease: parasite antigenic diversity

Lecture 11. Immunology and disease: parasite antigenic diversity Lecture 11 Immunology and disease: parasite antigenic diversity RNAi interference video and tutorial (you are responsible for this material, so check it out.) http://www.pbs.org/wgbh/nova/sciencenow/3210/02.html

More information

Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection

Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection The Harvard community has made this article openly available. Please share

More information

The first T cell response to transmitted/ founder virus contributes to the control of acute viremia in HIV-1 infection

The first T cell response to transmitted/ founder virus contributes to the control of acute viremia in HIV-1 infection Published Online: 1 June, 2009 Supp Info: http://doi.org/10.1084/jem.20090365 Downloaded from jem.rupress.org on December 10, 2018 ARTICLE The first T cell response to transmitted/ founder virus contributes

More information

Developing Understanding of CMI. Dr Tom Wilkinson Associate Professor of Respiratory Medicine Faculty of Medicine University of Southampton UK

Developing Understanding of CMI. Dr Tom Wilkinson Associate Professor of Respiratory Medicine Faculty of Medicine University of Southampton UK Pre-existing influenza-specific CD4+ T cells correlate with homologous and heterotypic response and disease protection against influenza challenge in humans Do At Risk Groups Rely more on CMI to Viruses?

More information

Originally published as:

Originally published as: Originally published as: Ratsch, B.A., Bock, C.-T. Viral evolution in chronic hepatitis B: A branched way to HBeAg seroconversion and disease progression? (2013) Gut, 62 (9), pp. 1242-1243. DOI: 10.1136/gutjnl-2012-303681

More information

Received 9 October 2008/Accepted 24 December 2008

Received 9 October 2008/Accepted 24 December 2008 JOURNAL OF VIROLOGY, Apr. 2009, p. 3556 3567 Vol. 83, No. 8 0022-538X/09/$08.00 0 doi:10.1128/jvi.02132-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Quantitating the Multiplicity

More information

COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1

COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1 Journal of Cell and Tissue Research Vol. 10(3) 2359-2364 (2010) ISSN: 0973-0028 (Available online at www.tcrjournals.com) Original Article COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN

More information

arxiv: v1 [q-bio.pe] 8 Sep 2015

arxiv: v1 [q-bio.pe] 8 Sep 2015 Population genomics of intrapatient HIV-1 evolution Fabio Zanini 1, Johanna Brodin 2, Lina Thebo 2, Christa Lanz 1, Göran Bratt 4, Jan Albert 2,3 and Richard A. Neher 1 1 Evolutionary Dynamics and Biophysics,

More information

RAISON D ETRE OF THE IMMUNE SYSTEM:

RAISON D ETRE OF THE IMMUNE SYSTEM: RAISON D ETRE OF THE IMMUNE SYSTEM: To Distinguish Self from Non-Self Thereby Protecting Us From Our Hostile Environment. Innate Immunity Acquired Immunity Innate immunity: (Antigen nonspecific) defense

More information

Host Genomics of HIV-1

Host Genomics of HIV-1 4 th International Workshop on HIV & Aging Host Genomics of HIV-1 Paul McLaren École Polytechnique Fédérale de Lausanne - EPFL Lausanne, Switzerland paul.mclaren@epfl.ch Complex trait genetics Phenotypic

More information

Ebola Virus. Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017

Ebola Virus. Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017 Ebola Virus Emerging Diseases Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017 Outline Disease emergence: a case study How do pathogens shift hosts? Evolution within hosts: The evolution

More information

Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection

Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection The Harvard community has made this article openly available. Please share how this access benefits you. Your story

More information

HIV-1 subtype C in Karonga District, Malawi. Simon Travers

HIV-1 subtype C in Karonga District, Malawi. Simon Travers HIV-1 subtype C in Karonga District, Malawi Simon Travers HIV-1; closely related to HIV found in chimps HIV-2; closely related to HIV found in mangabys Worldwide Distribution of HIV-1 group M subtypes

More information

HVTN Laboratory Program: Immunogenicity and Research Assays

HVTN Laboratory Program: Immunogenicity and Research Assays HVTN Laboratory Program: Immunogenicity and Research Assays Erica Andersen-Nissen, PhD Director, Cape Town HVTN Immunology Laboratory Considerations for a Pan-African HIV Vaccine Development Agenda Kigali,

More information

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load Holly Janes 1,2 *, Nicole Frahm 1,3, Allan DeCamp 1,

More information

Phylogenetic Analysis of HIV Samples from a Single Host

Phylogenetic Analysis of HIV Samples from a Single Host Phylogenetic Analysis of HIV Samples from a Single Host Master Thesis Rounak Vyas November 20, 2011 Advisors: Prof. Niko Beerenwinkel, Dr. Osvaldo Zagordi Computational Biology Group, ETH Zürich Contents

More information

Evidence of Differential HLA Class I- Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1

Evidence of Differential HLA Class I- Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 Evidence of Differential HLA Class I- Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 The Harvard community has made this article openly available. Please share how this

More information

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per

More information

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Modeling the Antigenic Evolution of Influenza Viruses from Sequences Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.

More information

HIV-1 adaptation to HLA: a window into virus-host immune interactions

HIV-1 adaptation to HLA: a window into virus-host immune interactions HIV-1 adaptation to HLA: a window into virus-host immune interactions Jonathan M. Carlson 1, Anh Q. Le 2, Aniqa Shahid 2, and Zabrina L. Brumme 2,3 1. Microsoft Research, Redmond, WA, USA 2. Faculty of

More information

Epitope discovery and Rational vaccine design Morten Nielsen

Epitope discovery and Rational vaccine design Morten Nielsen Epitope discovery and Rational vaccine design Morten Nielsen mniel@cbs.dtu.dk Bioinformatics in a nutshell List of peptides that have a given biological feature Mathematical model (neural network, hidden

More information

DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED

DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED Viv Peut Kent Laboratory, University of Melbourne, Australia WHY ENVELOPE? Env subject to both humoral and cellular immune responses Perhaps

More information

The molecular clock of HIV-1 unveiled through analysis of a known transmission history

The molecular clock of HIV-1 unveiled through analysis of a known transmission history Proc. Natl. Acad. Sci. USA Vol. 96, pp. 10752 10757, September 1999 Evolution The molecular clock of HIV-1 unveiled through analysis of a known transmission history THOMAS LEITNER, AND JAN ALBERT Theoretical

More information

The Swarm: Causes and consequences of HIV quasispecies diversity

The Swarm: Causes and consequences of HIV quasispecies diversity The Swarm: Causes and consequences of HIV quasispecies diversity Julian Wolfson Dept. of Biostatistics - Biology Project August 14, 2008 Mutation, mutation, mutation Success of HIV largely due to its ability

More information

The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates

The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates Bram Vrancken 1 *, Andrew Rambaut 2,3, Marc A. Suchard 4,5,6, Alexei Drummond

More information

Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System

Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System Joel O. Wertheim 1,2, Alexandra M. Oster 3, Jeffrey A. Johnson 3, William M. Switzer 3, Neeraja Saduvala

More information

Tracing HIV 1 transmission: envelope traits of HIV 1 transmitter and recipient pairs

Tracing HIV 1 transmission: envelope traits of HIV 1 transmitter and recipient pairs DOI 10.1186/s12977-016-0299-0 Retrovirology RESEARCH Open Access Tracing HIV 1 transmission: envelope traits of HIV 1 transmitter and recipient pairs Corinna S. Oberle 1,2, Beda Joos 1,2, Peter Rusert

More information

HHS Public Access Author manuscript Nat Med. Author manuscript; available in PMC 2016 November 16.

HHS Public Access Author manuscript Nat Med. Author manuscript; available in PMC 2016 November 16. HHS Public Access Author manuscript Published in final edited form as: Nat Med. 2016 June ; 22(6): 606 613. doi:10.1038/nm.4100. Impact of Pre-adapted HIV Transmission Jonathan M. Carlson 1, Victor Y.

More information

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood tree illustrating CRF01_AE gp120 protein sequence relationships between 107 Envs sampled in the RV144 trial

More information

(ii) The effective population size may be lower than expected due to variability between individuals in infectiousness.

(ii) The effective population size may be lower than expected due to variability between individuals in infectiousness. Supplementary methods Details of timepoints Caió sequences were derived from: HIV-2 gag (n = 86) 16 sequences from 1996, 10 from 2003, 45 from 2006, 13 from 2007 and two from 2008. HIV-2 env (n = 70) 21

More information

Development of a Universal T Cell Vaccine. Tomáš Hanke Weatherall Institute of Molecular Medicine University of Oxford United Kingdom

Development of a Universal T Cell Vaccine. Tomáš Hanke Weatherall Institute of Molecular Medicine University of Oxford United Kingdom Development of a Universal T Cell Vaccine Tomáš Hanke Weatherall Institute of Molecular Medicine University of Oxford United Kingdom Development of HIV-1 vaccines Induction of cell-mediated responses Immunogens

More information

HIV and drug resistance Simon Collins UK-CAB 1 May 2009

HIV and drug resistance Simon Collins UK-CAB 1 May 2009 HIV and drug resistance Simon Collins UK-CAB 1 May 2009 slides: thanks to Prof Clive Loveday, Intl. Clinical Virology Centre www.icvc.org.uk Tip of the iceberg = HIV result, CD4, VL Introduction: resistance

More information

Low-Dose Rectal Inoculation of Rhesus Macaques by SIVsmE660 or SIVmac251 Recapitulates Human Mucosal Infection by HIV-1

Low-Dose Rectal Inoculation of Rhesus Macaques by SIVsmE660 or SIVmac251 Recapitulates Human Mucosal Infection by HIV-1 Low-Dose Rectal Inoculation of Rhesus Macaques by SIVsmE660 or SIVmac251 Recapitulates Human Mucosal Infection by HIV-1 The Harvard community has made this article openly available. Please share how this

More information

MID-TERM EXAMINATION

MID-TERM EXAMINATION Epidemiology 227 May 2, 2007 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 75 questions and 11 pages on the examination. Each question will count one point. Notify

More information

Superior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design

Superior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design Superior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design Pratima Kunwar 1,7, Natalie Hawkins 2, Warren L. Dinges 1,3, Yi Liu 5, Erin E. Gabriel

More information

An Evolutionary Story about HIV

An Evolutionary Story about HIV An Evolutionary Story about HIV Charles Goodnight University of Vermont Based on Freeman and Herron Evolutionary Analysis The Aids Epidemic HIV has infected 60 million people. 1/3 have died so far Worst

More information

Finding protein sites where resistance has evolved

Finding protein sites where resistance has evolved Finding protein sites where resistance has evolved The amino acid (Ka) and synonymous (Ks) substitution rates Please sit in row K or forward The Berlin patient: first person cured of HIV Contracted HIV

More information

HIV-1 SUBTYPE C MOTHER-TO-CHILD TRANSMISSION: GENETIC AND IMMUNOLOGIC CORRELATES. Elizabeth Susan Russell

HIV-1 SUBTYPE C MOTHER-TO-CHILD TRANSMISSION: GENETIC AND IMMUNOLOGIC CORRELATES. Elizabeth Susan Russell HIV-1 SUBTYPE C MOTHER-TO-CHILD TRANSMISSION: GENETIC AND IMMUNOLOGIC CORRELATES Elizabeth Susan Russell A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial

More information

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group) AIDS Vaccine 07, Seattle, August 20-23, 2007 EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV (Summary of the recommendations from an Enterprise Working Group) The Working Group Reston, Virginia,

More information

Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement

Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement Leander Schietgat 1, Kristof Theys 2, Jan Ramon 1, Hendrik Blockeel 1, and Anne-Mieke Vandamme

More information

Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication

Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Oscar Blanch-Lombarte Rome, 7-9 June, 2017 European

More information

DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester

DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING John Archer Faculty of Life Sciences University of Manchester HIV Dynamics and Evolution, 2008, Santa Fe, New Mexico. Overview

More information

IAS 2015 Towards an HIV Cure symposium Vancouver Immune recognition following latency reversal

IAS 2015 Towards an HIV Cure symposium Vancouver Immune recognition following latency reversal IAS 2015 Towards an HIV Cure symposium Vancouver Immune recognition following latency reversal Marcus Altfeld Professor of Medicine Outline Immune recognition of HIV-1-infected cells Kinetics of antigen

More information

Exploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein

Exploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein Microbes Count! 137 Video IV: Reading the Code of Life Human Immunodeficiency Virus (HIV), like other retroviruses, has a much higher mutation rate than is typically found in organisms that do not go through

More information

A Path to an HIV Vaccine: GSID Consortium Activities. Faruk Sinangil, PhD 4th Annual CAVD Meeting Miami, FL December 1-4, 2009

A Path to an HIV Vaccine: GSID Consortium Activities. Faruk Sinangil, PhD 4th Annual CAVD Meeting Miami, FL December 1-4, 2009 A Path to an HIV Vaccine: GSID Consortium Activities Faruk Sinangil, PhD 4th Annual CAVD Meeting Miami, FL December 1-4, 2009 Project Goals Acquire and disseminate information that will contribute to the

More information

Increased sequence coverage through combined targeting of variant. and conserved epitopes correlates with control of HIV replication

Increased sequence coverage through combined targeting of variant. and conserved epitopes correlates with control of HIV replication JVI Accepts, published online ahead of print on 13 November 2013 J. Virol. doi:10.1128/jvi.02361-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Increased sequence coverage

More information

Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope

Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope Evering et al. Retrovirology 2014, 11:65 RESEARCH Open Access Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope Teresa H Evering 1*, Edwin Kamau 2, Leslie

More information

Deep-Sequencing of HIV-1

Deep-Sequencing of HIV-1 Deep-Sequencing of HIV-1 The quest for true variants Alexander Thielen, Martin Däumer 09.05.2015 Limitations of drug resistance testing by standard-sequencing Blood plasma RNA extraction RNA Reverse Transcription/

More information

Synonymous Substitution Rates Predict HIV Disease Progression as a Result of Underlying Replication Dynamics

Synonymous Substitution Rates Predict HIV Disease Progression as a Result of Underlying Replication Dynamics Synonymous Substitution Rates Predict HIV Disease Progression as a Result of Underlying Replication Dynamics Philippe Lemey 1*, Sergei L. Kosakovsky Pond 2, Alexei J. Drummond 3, Oliver G. Pybus 1, Beth

More information

Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants

Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants This manuscript is currently under consideration for publication in Viruses http://www.mdpi.com/journal/viruses Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies

More information

Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania

Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Dr. Fausta Franklin Mosha (MD, MSc, MSc, PHD) Ministry of Health and Social Welfare 22 nd October

More information

Estimating the mutational fitness effects distribution during early HIV infection

Estimating the mutational fitness effects distribution during early HIV infection Virus Evolution, 2018, 4(2): vey029 doi: 10.1093/ve/vey029 Research article Estimating the mutational fitness effects distribution during early HIV infection Eva Bons 1, *,, Frederic Bertels 1,2, and Roland

More information

Irina Maljkovic Berry

Irina Maljkovic Berry Thesis for doctoral degree (Ph.D.) 2008 Thesis for doctoral degree (Ph.D.) 2008 Genetic aspects of HIV-1 evolution and transmission Irina Maljkovic Berry Genetic aspects of HIV-1 evolution and transmission

More information

It is well known that some pathogenic microbes undergo

It is well known that some pathogenic microbes undergo Colloquium Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution Robin M. Bush, Catherine B. Smith, Nancy J. Cox, and Walter M. Fitch Department of

More information

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa African Journal of Biotechnology Vol. 10(24), pp. 4784-4793, 6 June, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB10.560 ISSN 1684 5315 2011 Academic Journals Full Length

More information

Received 4 August 2005/Accepted 7 December 2005

Received 4 August 2005/Accepted 7 December 2005 JOURNAL OF VIROLOGY, Mar. 2006, p. 2472 2482 Vol. 80, No. 5 0022-538X/06/$08.00 0 doi:10.1128/jvi.80.5.2472 2482.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Extensive Recombination

More information

High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity

High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1635 1641 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.01478-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. High Failure

More information

Defining kinetic properties of HIV-specific CD8 + T-cell responses in acute infection

Defining kinetic properties of HIV-specific CD8 + T-cell responses in acute infection Defining kinetic properties of HIV-specific CD8 + T-cell responses in acute infection Yiding Yang 1 and Vitaly V. Ganusov 1,2,3 1 Department of Microbiology, University of Tennessee, Knoxville, TN 37996,

More information

Did the surgeon give hepatitis C to his patient?

Did the surgeon give hepatitis C to his patient? ForensicEA Lite Tutorial Did the surgeon give hepatitis C to his patient? In a recent issue of the Journal of Medical Virology, R. Stephan Ross and colleagues (2002) report the story of a German surgeon

More information

From Mosquitos to Humans: Genetic evolution of Zika Virus

From Mosquitos to Humans: Genetic evolution of Zika Virus Article: From Mosquitos to Humans: Genetic evolution of Zika Virus Renata Pellegrino, PhD Director, Sequencing lab Center for Applied Genomics The Children s Hospital of Philadelphia Journal Club Clinical

More information

ANALYSIS OF HOST AND VIRAL FACTORS IN THE ELITE SUPPRESSION OF HIV-1 INFECTION. Robert W. Buckheit III

ANALYSIS OF HOST AND VIRAL FACTORS IN THE ELITE SUPPRESSION OF HIV-1 INFECTION. Robert W. Buckheit III ANALYSIS OF HOST AND VIRAL FACTORS IN THE ELITE SUPPRESSION OF HIV-1 INFECTION By Robert W. Buckheit III A dissertation submitted to Johns Hopkins University in conformity with the requirements for the

More information

Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection

Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection University of Massachusetts Medical School escholarship@umms Open Access Articles Open Access Publications by UMMS Authors 9-26-2013 Rapid intrahost evolution of human cytomegalovirus is shaped by demography

More information

HIV and Challenges of Vaccine Development

HIV and Challenges of Vaccine Development Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health HIV and Challenges of Vaccine Development Richard A. Koup, MD INTEREST

More information

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of

More information